Catalyst
Slingshot members are tracking this event:
Biogen (BIIB) Presents Phase 1b Data on Aducanumab in Early Alzheimer's Disease at the 9th Clinical Trials on Alzheimer's Disease (CTAD) Meeting
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| BIIB |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 08, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Aducanumab, Phase 1b, Early Alzheimer's Disease, 9th Clinical Trials On Alzheimer's Disease, Ctad
